Search results for " QbD"
								 					Article
				
				Security of Supply
								Getting high-quality biotherapeutics to patients on time requires a concerted effort. Working together, suppliers and manufacturers can better understand raw materials and variations that put processe…								
								 					Article
				
				The Good and Bad of Biosimilars
								
	Biosimilars have been around for years, but the biopharma industry – as well as the healthcare community – has been slow to embrace them. Today, however, the competition is really beginning to heat …								
								 					Article
				
				Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars
								Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars
	A major advantage of SPR-based analysis is its ability to estimate the association and dissociation rate constants, an …								
								 					Article
				
				Why, Why, Why…ELISA? A Look at the Benchmark HCP Assay
								
	Click here to read the article >>
	
Biologics developers and manufacturers demand an accurate and reliable assay for host cell protein (HCP) quantitation. Let’s take a close look at why analytica…								
								 					Article
				
				Sensitive and Reproducible SPR-Based Concentration and Ligand-Binding Analyses
								Surface plasmon resonance (SPR) assays are used across the life cycle of a biopharmaceutical, from target identification, through CQA determination, development, and on-going quality control. This art…								
								 					Article
				
				Make the Switch from ELISA to Biacore™ SPR-Based Assays Today
								General guidance on how to convert an existing ELISA assay to a Biacore surface plasmon resonance (SPR) assay and how, by doing so, you can get results in less than half the time compared with ELISA. …								
								 					Article
				
				Advances in Engineering of Protein-Based APIs
								Advances in Engineering of Protein-Based APIs
	New platform technologies, advanced modeling tools, and addressing patient needs are important developments.
	
		
	
	
		By Cynthia A. Challener
	
	
…								
								 					Article
				
				Achieve Scalable Viral Vector Production
								In our tutorial series on viral vector production, Cytiva scientists share their insights on virus production and how to tackle viral vector manufacturing challenges. In this episode, a scalable produ…								
								 					Article
				
				Supply Chain Challenges for Single-Use Systems
								
	Suppliers address the complexity of supplying disposable components to the global biopharmaceutical manufacturing industry. 
	
	  
	
	
	By Jennifer Markarian  
	
	
	 
	The implementation of sing…								
								 					Article
				
				Ensure SEC Column Reproducibility in Protein Drug Analysis
								Size exclusion chromatography (SEC) is the go-to analytical method in the analysis of therapeutic protein drugs. This article describes the factors affecting the reproducibility of columns and how you…